Sarchet determines which genes influence the placebo effect and how they determine someone's susceptibility to it. Symptoms of conditions such as migraine, depression, irritable bowel syndrome and even Parkinson's disease seem to be relieved by placebo in some individuals. Screening for placebo responders could also help design more balanced clinical trials. There is some evidence that brain imaging can identify people that fall into this category, but a genetic read-out would offer a convenient and dearly codified measure. So far, the 11 genes implicated in the placebo response are all involved in neurotransmitter pathways
© 2001-2026 Fundación Dialnet · Todos los derechos reservados